摘要
顽固性心绞痛是指传统的抗心绞痛药物均无效 ,又不适合做冠状动脉内介入治疗和冠脉搭桥术的心绞痛。新的药物治疗 (新的抗血小板药物、低分子肝素、溶栓药物、抗心肌缺血的代谢疗法 )、神经刺激、增强的体外反搏、激光血管重建术、基因治疗、经皮穿刺心肌静脉动脉化。
The refractory angina pectoris is termed according to the failure of all traditional anti-angina treatment with simultaneously not suitable for percutaneous coronary interventions and coronary artery bypass graft surgery. New drug treatment (new anti-platelet drugs, low-molecular-weight heparins, thrombolytic agents, metabolic treatment for ischaemia), neurostimulation, enhanced external counterpulsation, laser revascularization, gene therapy, percutaneous coronary venous arterialization and heart transplantation may represent nowadays new explore for the treatment of refractory angina pectoris.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2004年第10期708-712,共5页
Chinese Journal of New Drugs and Clinical Remedies
关键词
心绞痛
激光
基因
药物疗法
血小板聚
集抑制剂
抗凝药
体外反搏
angina pectoris
laser
gene
drug therapy
platelet aggregation inhibitors
anticoagulants
external counter pulsation
